Mark Andrew Wilson, Chief Legal Officer at NEKTAR THERAPEUTICS (NKTR), sold 7,606 shares at $0.68 ($5K) on 2024-02-20, disclosed to the SEC on 2024-02-22.
Seasonal sale ($5k) by Chief Legal Officer — this insider has traded NKTR in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NKTR | SELL | 2025-05-21 | $7K | — | Filing → |
| NKTR | SELL | 2025-02-21 | $11K | — | Filing → |
| NKTR | SELL | 2024-12-26 | $45K | — | Filing → |